Published in Biostatistics on December 01, 2002
The quadratic hazard model for analyzing longitudinal data on aging, health, and the life span. Phys Life Rev (2012) 2.87
Basic concepts and methods for joint models of longitudinal and survival data. J Clin Oncol (2010) 2.41
Stochastic model for analysis of longitudinal data on aging and mortality. Math Biosci (2006) 1.61
Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials. Stat Med (2014) 1.01
Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data. BMC Med Res Methodol (2010) 0.93
Survival Analysis with Time-Varying Covariates Measured at Random Times by Design. J R Stat Soc Ser C Appl Stat (2013) 0.86
Prediction of coronary artery disease risk based on multiple longitudinal biomarkers. Stat Med (2015) 0.82
Joint modeling of survival time and longitudinal data with subject-specific changepoints in the covariates. Stat Med (2010) 0.82
Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation. Epidemiology (2015) 0.80
Proportional Hazards Model with Covariate Measurement Error and Instrumental Variables. J Am Stat Assoc (2014) 0.78
A semiparametric copula method for Cox models with covariate measurement error. Lifetime Data Anal (2014) 0.77
Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues. BMC Med Res Methodol (2016) 0.77
Sample size requirements for training high-dimensional risk predictors. Biostatistics (2013) 0.77
AN APPROACH FOR JOINTLY MODELING MULTIVARIATE LONGITUDINAL MEASUREMENTS AND DISCRETE TIME-TO-EVENT DATA. Ann Appl Stat (2010) 0.76
Cocaine Dependence Treatment Data: Methods for Measurement Error Problems With Predictors Derived From Stationary Stochastic Processes. J Am Stat Assoc (2011) 0.75
Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling. Lifetime Data Anal (2016) 0.75
Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data with Applications to Cancer Clinical Trials. J Comput Graph Stat (2017) 0.75
Joint Models for Multiple Longitudinal Processes and Time-to-event Outcome. J Stat Comput Simul (2016) 0.75
Performance of joint modelling of time-to-event data with time-dependent predictors: an assessment based on transition to psychosis data. PeerJ (2016) 0.75
Locally Efficient Semiparametric Estimators for Proportional Hazards Models with Measurement Error. Scand Stat Theory Appl (2015) 0.75
Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med (2004) 10.65
Comment: Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data. Stat Sci (2007) 6.65
Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med (2008) 4.33
Semiparametric Estimation of Treatment Effect in a Pretest-Posttest Study with Missing Data. Stat Sci (2005) 3.90
Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach. Stat Med (2008) 3.83
A robust method for estimating optimal treatment regimes. Biometrics (2012) 3.76
Median regression with censored cost data. Biometrics (2002) 3.34
Improving efficiency of inferences in randomized clinical trials using auxiliary covariates. Biometrics (2008) 3.04
A semiparametric likelihood approach to joint modeling of longitudinal and time-to-event data. Biometrics (2002) 2.74
Improving efficiency and robustness of the doubly robust estimator for a population mean with incomplete data. Biometrika (2009) 2.61
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation (2006) 2.60
Semiparametric estimation of treatment effect in a pretest-posttest study. Biometrics (2003) 2.53
Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics (2002) 2.50
The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol (2004) 2.34
Conditional estimation for generalized linear models when covariates are subject-specific parameters in a mixed model for longitudinal measurements. Biometrics (2004) 2.26
Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics (2004) 2.07
Estimating Optimal Treatment Regimes from a Classification Perspective. Stat (2012) 1.95
Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. Am J Epidemiol (2004) 1.94
Doubly robust estimation of causal effects. Am J Epidemiol (2011) 1.66
Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions. Biometrika (2013) 1.59
Comparison between two partial likelihood approaches for the competing risks model with missing cause of failure. Lifetime Data Anal (2005) 1.54
Gene-trait similarity regression for multimarker-based association analysis. Biometrics (2009) 1.44
"Smooth" semiparametric regression analysis for arbitrarily censored time-to-event data. Biometrics (2007) 1.41
A Monte Carlo EM algorithm for generalized linear mixed models with flexible random effects distribution. Biostatistics (2002) 1.40
Adaptive two-stage designs in phase II clinical trials. Stat Med (2006) 1.38
Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout. Biometrics (2010) 1.23
The analysis of multivariate longitudinal data: a review. Stat Methods Med Res (2012) 1.22
Smoothing spline-based score tests for proportional hazards models. Biometrics (2006) 1.14
Why statistics? Science (2012) 1.13
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J (2005) 1.12
Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling. Biometrics (2013) 1.09
On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential trials, random sample sizes, and missing data. Stat Methods Med Res (2012) 1.09
'Smooth' inference for survival functions with arbitrarily censored data. Stat Med (2008) 0.97
Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. Stat Med (2008) 0.96
Likelihood and Pseudo-likelihood Methods for Semiparametric Joint Models for a Primary Endpoint and Longitudinal Data. Comput Stat Data Anal (2007) 0.95
Estimating mean response as a function of treatment duration in an observational study, where duration may be informatively censored. Biometrics (2004) 0.93
A moment-adjusted imputation method for measurement error models. Biometrics (2011) 0.91
Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial. Biostatistics (2010) 0.89
Mixed model analysis of censored longitudinal data with flexible random-effects density. Biostatistics (2011) 0.87
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods. Circulation (2004) 0.86
Multiple imputation approaches for the analysis of dichotomized responses in longitudinal studies with missing data. Biometrics (2010) 0.86
Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection. Drug Alcohol Depend (2007) 0.86
Non-linear Models for Longitudinal Data. Am Stat (2009) 0.85
Latent-model robustness in joint models for a primary endpoint and a longitudinal process. Biometrics (2009) 0.85
Assessing the causal effect of organ transplantation on the distribution of residual lifetime. Biometrics (2013) 0.84
Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials. Stat Med (2012) 0.83
Experimental statistics for biological sciences. Methods Mol Biol (2010) 0.80
Moment Adjusted Imputation for Multivariate Measurement Error Data with Applications to Logistic Regression. Comput Stat Data Anal (2013) 0.78
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy). Am J Cardiol (2004) 0.77
Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring. Lifetime Data Anal (2011) 0.75
Discussion of "Connections Between Survey Calibration Estimators and Semiparametric Models for Incomplete Data" by T. Lumley, P.A. Shaw & J.Y. Dai. Int Stat Rev (2011) 0.75
Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed. Lifetime Data Anal (2013) 0.75
Response to reader reaction. Biometrics (2014) 0.75
Surgeons' economic profiles: can we get the "right" answers? J Med Syst (2005) 0.75
Biometrics. Report of the editors--2011. Biometrics (2012) 0.75